Law360, New York (June 1, 2012, 1:07 PM EDT) -- David Greenwald is a partner in the litigation department of Cravath Swaine & Moore LLP in the firm's New York office. He has represented pharmaceutical companies, biotech companies and research universities in patent infringement cases. Recent cases have included several Hatch-Waxman Act challenges and cases involving transcriptional regulators. Greenwald is a regular lecturer on intellectual property and general litigation subjects. He holds an undergraduate degree in biochemistry.
Q: What is the most challenging case you have worked on and what made it challenging?
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.